ResearcherXuzhou Medical CollegeNo recent work listed

Hui Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7669-9386; OpenAlex author ID A5100387609. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 13

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

Loss of Heterozygosity for Kras G12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism. Last author DOI 10.3390/ijms23126697 ↗
Tumor innervation and clinical outcome in pancreatic cancer. Co-author DOI 10.1038/s41598-021-86831-w ↗
Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer. Co-author DOI 10.1159/000495281 ↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu Ma · 1 shared paper, 2022 · strength 0.17
- Paper Loss of Heterozygosity for Kras G12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF… DOI 10.3390/ijms23126697 ↗
Mingyue Hu · 1 shared paper, 2022 · strength 0.17
- Paper Loss of Heterozygosity for Kras G12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF… DOI 10.3390/ijms23126697 ↗
Sunkai Ling · 1 shared paper, 2022 · strength 0.17
- Paper Loss of Heterozygosity for Kras G12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF… DOI 10.3390/ijms23126697 ↗
Bo Kong · 1 shared paper, 2022 · strength 0.17
- Paper Loss of Heterozygosity for Kras G12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF… DOI 10.3390/ijms23126697 ↗
Peilin Huang · 1 shared paper, 2022 · strength 0.17
- Paper Loss of Heterozygosity for Kras G12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF… DOI 10.3390/ijms23126697 ↗
Aysha Ferdoushi · 1 shared paper, 2021 · strength 0.12
- Paper Tumor innervation and clinical outcome in pancreatic cancer. DOI 10.1038/s41598-021-86831-w ↗
Hubert Hondermarck · 1 shared paper, 2021 · strength 0.12
- Paper Tumor innervation and clinical outcome in pancreatic cancer. DOI 10.1038/s41598-021-86831-w ↗
Fangfang Gao · 1 shared paper, 2021 · strength 0.12
- Paper Tumor innervation and clinical outcome in pancreatic cancer. DOI 10.1038/s41598-021-86831-w ↗
Peng Jiang · 1 shared paper, 2018 · strength 0.07
- Paper Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancrea… DOI 10.1159/000495281 ↗
Jie Li · 1 shared paper, 2018 · strength 0.07
- Paper Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancrea… DOI 10.1159/000495281 ↗
Xiangde Liu · 1 shared paper, 2018 · strength 0.07
- Paper Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancrea… DOI 10.1159/000495281 ↗
Xiaoya Wang · 1 shared paper, 2018 · strength 0.07
- Paper Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancrea… DOI 10.1159/000495281 ↗
Zhonghu Li · 1 shared paper, 2018 · strength 0.07
- Paper Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancrea… DOI 10.1159/000495281 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.